How much does a box of macitentan tablets cost? Summary of selling prices in pharmacies in various regions

Macitentan (Macitentan) tablets have been launched in China and have been included in medical insurance, becoming a commonly used targeted drug for the treatment of patients with pulmonary arterial hypertension (PAH). The domestic original drug specification is 10mg*30 tablets, and each box sells for about 4,000 yuan. Thanks to medical insurance support, patients who qualify for reimbursement can alleviate certain financial burdens, making treatment more accessible.

The selling prices of pharmacies in different regions may vary slightly, which is mainly affected by hospital procurement costs, regional economic levels and drug circulation links. In pharmacies of large tertiary hospitals in first-tier cities, prices are usually close to official retail prices; in second- or third-tier cities, prices may be slightly lower or higher, but the overall fluctuation range is not large, and they are all within the scope of medical insurance reimbursement.

In overseas markets, macitentan is also on the market, and generics are available. Take the generic drugs produced by Lao pharmaceutical factories as an example. The specifications are the same as the original drugs. Each box sells for about more than 300 yuan. The price is much lower than the original drugs. However, the drug ingredients and efficacy are basically the same, providing an alternative option for patients with limited economic conditions. When purchasing drugs overseas, you need to pay attention to legal channels and drug storage and transportation conditions to ensure drug safety.

Overall, the price of the domestic original drug macitentan is stable and has been included in medical insurance. Patients can purchase it through regular hospital pharmacies and enjoy reimbursement policies; low-priced generic drugs exist in overseas markets, but access is limited and international drug import regulations need to be followed. For patients, rational selection of drug purchase channels and understanding of cost policies can help ensure continuous and safe treatment.

Reference materials:https://www.drugs.com/